Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNY3P10 is a pseudogene belonging to the Y RNA family, which is a group of small non-coding RNAs structurally related to the canonical RNY3 RNA. The Y RNA family comprises stem-loop structured RNAs found predominantly in ribonucleoprotein complexes with the Ro60 protein. Canonical Y RNAs like RNY3 play roles in RNA quality control, DNA replication, and immune modulation; however, pseudogenes such as RNY3P10 are generally regarded as nonfunctional but may exert subtle regulatory effects through RNA-level mechanisms such as competition for RNA-binding proteins or acting as competing endogenous RNAs. There is no evidence that RNY3P10 has a direct function, disease role, or relevance as a therapeutic target. The current scientific literature focuses on functional Y RNAs rather than their pseudogenes[6][2]. If targeting or biomarker use for this specific pseudogene is required, more evidence would be needed, as current data suggests no validated therapeutic or biomarker relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, Ro-associated Y3 pseudogene 10 (RNY3P10).